Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1592 | Thyroid (non-cancer) | ICEECE2012

Recurrence of Amiodarone induced thyrotoxicosis after reinstitution of this drug

Maqdasy S. , Batisse-Lignier M. , Lusson J. , Lamaison D. , Citron B. , Roche B. , Desbiez F. , Thieblot P. , Tauveron I.

Introduction: Amiodarone-induced thyrotoxicosis (AIT) contributes to increased morbidity and mortality in patients invariably having underlying heart disease. In clinical practice, amiodarone therapy often needs to be restarted. When amiodarone is reintroduced, what happens then?Objective: The aim of study is to evaluate the progression of thyroid function after reinstitution of amiodarone in patients with a previous history of AIT. Secondarily, to deter...

ea0029p1831 | Thyroid cancer | ICEECE2012

Prostate and bladder metastasis of Medullary Thyroid Carcinoma

Maqdasy S. , Batisse-Lignier M. , Costes-Chalret N. , Boiteux J. , Roche B. , Chollet P. , Tauveron I. , Thieblot P.

Introduction: Medullary thyroid carcinoma MTC represents 5% of all thyroid cancers. It is familial in 30% of the cases. The most frequent metastatic localizations are lymph nodes, liver, lung and bone. We describe prostatic and vesical localizations of a MTC in a patient with multiple endocrine neoplasia (MEN 2B).Case report: A 44 years old patient with MEN 2B operated in 1989 for MTC, bilateral pheochromocytoma and had a cutanuous neurofibroma. He prese...